APPLICATION SITE EXTRAVASATION

APPLICATION SITE EXTRAVASATION was reported 75 times

APPLICATION SITE EXTRAVASATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 Leukocyte Growth Factor [EPC] 40 0.0003
2 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2 0.0001
3 Human Immunoglobulin G [EPC] 2 0.0001
4 Lipid-based Polyene Antifungal [EPC] 1 0.0001
5 Radiographic Contrast Agent [EPC] 2 0.0001
6 Antimetabolite Immunosuppressant [EPC] 1 0.0000
7 PCSK9 Inhibitor [EPC] 1 0.0000
8 Polyene Antifungal [EPC] 1 0.0000
9 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
10 Ester Local Anesthetic [EPC] 1 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
12 Proteasome Inhibitor [EPC] 2 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Tetracycline-class Drug [EPC] 1 0.0000
15 HER2/neu Receptor Antagonist [EPC] 1 0.0000
16 Non-Standardized Chemical Allergen [EPC] 1 0.0000
17 Catecholamine [EPC] 1 0.0000
18 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
19 Integrin Receptor Antagonist [EPC] 1 0.0000
20 Amide Local Anesthetic [EPC] 1 0.0000
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
22 Antiarrhythmic [EPC] 1 0.0000
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
24 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
25 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
26 alpha-Adrenergic Blocker [EPC] 1 0.0000
27 Calcium [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 2 0.0000
29 Corticosteroid [EPC] 7 0.0000
30 Estrogen [EPC] 1 0.0000
31 Alkylating Drug [EPC] 1 0.0000
32 Platinum-based Drug [EPC] 1 0.0000
33 Progestin [EPC] 1 0.0000
34 Osmotic Laxative [EPC] 1 0.0000
35 Vitamin D [EPC] 1 0.0000
36 Vitamin B12 [EPC] 1 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
38 Vitamin C [EPC] 1 0.0000
39 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
40 Proton Pump Inhibitor [EPC] 1 0.0000
41 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000